Article
Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery.
Arteriosclerosis, thrombosis, and vascular biology - 1 Feb 2005
Sakamoto Kenichi, Murata Takahisa, Chuma Hiroko, Hori Masatoshi, Ozaki Hiroshi
Abstract excerpt
OBJECTIVE: We examined the inhibitory mechanisms of fluvastatin on FBS-induced vascular hypertrophy assessed by organ-cultured rat tail artery. METHODS AND RESULTS: After 5 days of culture with 10% FBS, hyperplastic morphological changes in the media layer were induced. Treatment with 1 mumol/L fluvastatin significantly inhibited these changes. In the FBS-cultured arteries, the protein expression ratio of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
